The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Riehemann Walter E since 2006.
The trader's CIK number is 1332019.
At the time of the last reporting, Riehemann Walter E was the EVP, General Counsel of Adams Respiratory Therapeutics, Inc.. (stock ticker symbol ARXT).
Also see all insider trading activities at Adams Respiratory Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | ARXT | 0 | $0 | 38,835 | $1,601,582 | 38,835 | $175,674 |
| 2006 | ARXT | 0 | $0 | 52,873 | $2,190,418 | 52,873 | $327,856 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-10-05 | ARXT | Option Ex | 19,305 | .40 | 7,722 |
| 2007-10-05 | ARXT | Sale | 19,305 | 40.00 | 772,200 |
| 2007-08-03 | ARXT | Option Ex | 9,000 | 17.00 | 153,000 |
| 2007-08-03 | ARXT | Sale | 9,000 | 40.00 | 360,000 |
| 2007-01-29 | ARXT | Sale | 3,099 | 44.46 | 137,772 |
| 2007-01-29 | ARXT | Option Ex | 5,265 | 1.42 | 7,476 |
| 2007-01-29 | ARXT | Sale | 2,166 | 44.75 | 96,919 |
| 2007-01-29 | ARXT | Sale | 3,099 | 44.46 | 137,772 |
| 2007-01-29 | ARXT | Option Ex | 5,265 | 1.42 | 7,476 |
| 2007-01-29 | ARXT | Sale | 2,166 | 44.75 | 96,919 |
| 2006-11-10 | ARXT | Option Ex | 19,305 | .40 | 7,722 |
| 2006-11-10 | ARXT | Sale | 10,083 | 42.04 | 423,889 |
| 2006-11-10 | ARXT | Sale | 9,222 | 42.29 | 389,970 |
| 2006-07-20 | ARXT | Sale | 8,999 | 42.35 | 381,107 |
| 2006-07-20 | ARXT | Option Ex | 8,999 | 17.00 | 152,983 |
| 2006-07-20 | ARXT | Sale | 8,999 | 42.35 | 381,107 |
| 2006-07-20 | ARXT | Option Ex | 8,999 | 17.00 | 152,983 |
| 2006-03-31 | ARXT | Option Ex | 11,677 | .91 | 10,626 |
| 2006-04-03 | ARXT | Option Ex | 3,893 | .91 | 3,542 |
| 2006-03-31 | ARXT | Sale | 11,677 | 39.28 | 458,625 |
| 2006-04-03 | ARXT | Sale | 3,893 | 40.00 | 155,720 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Riehemann Walter E (EVP, General Counsel of Adams Respiratory Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.